Plasma testosterone levels in patients with prostatic carcinoma before and after treatment

HH Young, JR Kent - The Journal of Urology, 1968 - auajournals.org
METHODS Patients at Wadsworth Veterans Hospital were classified into the stage of their
disease according to established criteria. 12 Twenty-eight patients with stage 3 or 4 disease …

Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma

JR Kent, AJ Bischoff, LJ Arduino… - The Journal of …, 1973 - auajournals.org
RESULTS Pre-treatment testosterone levels. Among the 68 patients with stage III disease
the plasma testosterone was 0.56 plus or minus 0.257 µg. per 100 ml.(mean plus or minus …

Pre-treatment testosterone levels: significance in androgen deprivation therapy

D Hickey, B Todd, MS Soloway - The Journal of urology, 1986 - Elsevier
Abstract From June 1982 to February 1985, 53 patients with stage D2 carcinoma of the
prostate confirmed by tissue biopsy, elevated prostatic acid phosphatase and a positive …

Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma.

P Iversen, F Rasmussen… - Scandinavian journal of …, 1994 - europepmc.org
In 245 patients with previously untreated advanced carcinoma of the prostate, serum
concentrations of testosterone have been measured before androgen deprivation therapy …

[引用][C] Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer

RJ Shearer, WF Hendry, IF Sommerville… - British Journal of …, 1973 - Wiley Online Library
Plasma testosterone has been estimated by radioimmunoassay in 109 patients with
prostatic carcinoma and 18 men of similar age with benign prostatic hyperplasia. Stilboestrol …

Plasma testosterone production rates in patients with prostatic cancer and benign prostatic hypertrophy

K Isurugi - The Journal of Urology, 1967 - auajournals.org
Since Huggins and Hodges demonstrated androgen-dependence of prostatic cancer, 1
many investigators have shown that anti-androgenic treatment, including estrogen …

Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy

J Geller, JD Albert, DA Nachtsheim, D Loza - The Journal of urology, 1984 - Elsevier
Dihydrotestosterone concentrations have been measured in prostatic tissue from patients
with recurrent advanced prostatic cancer after 1.0 to 5.0 mg. diethylstilbestrol per day or …

Response of men with advanced prostatic carcinoma to exogenous administration of testosterone

GR Prout Jr, WR Brewer - Cancer, 1967 - Wiley Online Library
Twenty‐six men in whom the diagnosis of prostatic carcinoma had been established
recently and ten men with prostatic carcinoma in relapse after orchiectomy were …

Effect of orchidectomy on serum concentrations of testosterone and dihydrotestosterone in patients with prostatic cancer

HF Røhl, HP Beuke - Scandinavian journal of urology and …, 1992 - Taylor & Francis
Because it is well known that prostatic cancer is dependent on testosterone, and that
dihydrotestosterone is the active mediator of the androgen action in the prostatic cell, we …

Plasma testosterone in patients receiving diethylstilbestrol

PH Beck, JW McAninch, JL Goebel, RE Stutzman - Urology, 1978 - Elsevier
With accurate, inexpensive plasma testosterone assays now available it is possible to
monitor the efficacy of hormonal manipulation in the patient with adenocarcinoma of the …